Joyn Revenue and Competitors
Estimated Revenue & Valuation
- Joyn's estimated annual revenue is currently $2.5M per year.
- Joyn's estimated revenue per employee is $101,500
Employee Data
- Joyn has 25 Employees.
- Joyn grew their employee count by -29% last year.
Joyn's People
Name | Title | Email/Phone |
---|
Joyn Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $28630M | 16399 | -2% | $121.9B | $232.9B |
#2 | $457970M | 811799 | -10% | N/A | $1.6T |
#3 | $31.9M | 118 | -2% | $520M | N/A |
What Is Joyn?
Due to international digitalization, retailers of consumer goods and services have to find creative ways to increase customer retention, in order to receive and increase recurrent revenues. Having a loyal customer base is key! Joyn offers a B2B Loyalty/customer engagement Platform-as-a-Service integrated with an easy to use business application for point-of-sale use, and additional services to help increase loyalty between retailers and their customers even more. This user friendly and flexible solution to create loyalty programs caters the needs of every retailer, large or small. Contact us at hello@joyn.eu for more information and visit our website: https://loyalty.joyn.eu/
keywords:N/AN/A
Total Funding
25
Number of Employees
$2.5M
Revenue (est)
-29%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Joyn News
The announcement signals the winding down of Joyn Bio, a joint venture the two companies started in 2017 to explore how to make more...
Joyn Bio is a joint venture founded by Bayer and Ginkgo Bioworks developing probiotics for plants to provide growers with next generation...
Joyn Bio is bringing synthetic biology to agriculture for better ways to feed the world. A joint venture between Leaps by Bayer and Ginkgo...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $5.2M | 45 | -12% | N/A |
#2 | $14M | 100 | -5% | N/A |
#3 | $22.4M | 102 | -5% | N/A |
#4 | N/A | 106 | 31% | N/A |
#5 | $1630M | 3644 | 6% | N/A |